Bain Capital Life Sciences Investors, LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1703031 Boston, MA

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,418,482

-$224,944 QoQ

Shares Held

362,470

-51.3% QoQ

Ownership

0.663%

of shares outstanding

% of Portfolio

2.76%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bain Capital Life Sciences Investors, LLC holds $806,308,171 across 15 Biotechnology names. DNTH ranks #7 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NAMS	NewAmsterdam Pharma Co N.V.	7,306,566	$233,883,177
2	OLMA	Olema Pharmaceuticals, Inc.	7,473,238	$111,425,978
3	SVRA	Savara Inc	17,600,621	$96,099,390
4	PHVS	Pharvaris N.V.	2,675,509	$75,583,129
5	SLDB	Solid Biosciences Inc.	9,808,819	$70,623,496
6	XFOR	X4 Pharmaceuticals, Inc	7,967,454	$32,905,585
7	DNTH	Dianthus Therapeutics, Inc. /DE/ This page	362,470	$30,418,482
8	ANNX	Annexon, Inc.	5,212,674	$28,878,213

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,418,482	362,470	-51.3%	Shares	Sole	2026-05-15
2025-12-31	$30,643,426	743,592	-43.5%	Shares	Sole	2026-02-17
2025-09-30	$51,780,350	1,315,892	-47.0%	Shares	Sole	2025-11-14
2025-06-30	$46,244,317	2,482,250	-7.7%	Shares	Sole	2025-08-14
2025-03-31	$48,791,284	2,689,707	0.0%	Shares	Sole	2025-05-15
2024-12-31	$58,635,612	2,689,707	-10.7%	Shares	Sole	2025-02-14
2024-09-30	$82,507,521	3,013,423	0.0%	Shares	Sole	2024-11-14
2024-06-30	$77,987,387	3,013,423	+0.7%	Shares	Sole	2024-08-12
2024-03-31	$89,760,840	2,992,028	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.